Drugs / Citrafleet®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07696793 | May 2026 → May 2028 expected | colorectal cancer | Fundacion Clinic per a la Recerca Biomédica | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Citrafleet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07696793 ↗ |
| Route | Oral | “powder for oral solution in sachet” NCT07696793 ↗ |